These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18312972)

  • 61. Comments on the calibration of pre-cut iridium-192 wires for low dose rate interstitial brachytherapy using a farmer-type ionization chamber.
    Plane JH
    Br J Radiol; 2001 Mar; 74(879):291-3. PubMed ID: 11338112
    [No Abstract]   [Full Text] [Related]  

  • 62. [Current possibilities of utilizing covert sources of radiation in brachytherapy for neoplasia].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 2007; 53(6):690-5. PubMed ID: 18416139
    [No Abstract]   [Full Text] [Related]  

  • 63. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.
    Erickson BA; Bittner NH; Chadha M; Mourtada F; Demanes DJ
    Brachytherapy; 2017; 16(1):75-84. PubMed ID: 28109634
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brachytherapy partial breast irradiation: analyzing effect of source configurations on dose metrics relevant to toxicity.
    Cormack RA; Devlin PM
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):940-4. PubMed ID: 18514786
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of radiation therapy in prostate cancer.
    Amin PP
    Prog Clin Biol Res; 1988; 277():119-26. PubMed ID: 3141934
    [No Abstract]   [Full Text] [Related]  

  • 66. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
    Ares C; Popowski Y; Pampallona S; Nouet P; Dipasquale G; Bieri S; Ozsoy O; Rouzaud M; Khan H; Miralbell R
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):656-63. PubMed ID: 19250768
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A system for nonradiographic source localization and real-time planning of intraoperative high dose rate brachytherapy.
    Watanabe Y; Anderson LL
    Med Phys; 1997 Dec; 24(12):2014-23. PubMed ID: 9434985
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Visual method of confirming cervical intracavitary implant adequacy and triage of patients for computer dosimetry.
    Dowlatshahi M; Neville CR; Kagan AR; Rao A; Semrad N; Holland K; Peddada AV; Tome M; Miller M; Ryoo J; Wang R; Iganej S
    J Oncol Manag; 1998; 7(1):26-30. PubMed ID: 10179006
    [No Abstract]   [Full Text] [Related]  

  • 69. Implantation of iodine-125 seeds as a form of intraoperative brachytherapy.
    Sauerwein W; Müller B; Meyer-Schwickerath M; Hoederath A; Eigler FW; Busch M; Sack H
    Ann Radiol (Paris); 1989; 32(6):515-22. PubMed ID: 2517386
    [No Abstract]   [Full Text] [Related]  

  • 70. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
    Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acceptance testing, commissioning and quality assurance for a 370 GBq 192Ir HDR brachytherapy afterloader.
    Wallace AB
    Australas Phys Eng Sci Med; 1997 Jun; 20(2):112-6. PubMed ID: 9262031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Physics and dosimetry of afterloading therapy of hypopharyngeal cancer].
    Pohlmann S; Brock A; Prager W
    Radiobiol Radiother (Berl); 1989; 30(4):361-2. PubMed ID: 2798800
    [No Abstract]   [Full Text] [Related]  

  • 74. Comments on "Reference Dose Rates for Single- and Double-Plane 192Ir Implants".
    Olch AJ; Kagan AR
    Med Phys; 1989; 16(1):143-4. PubMed ID: 2921976
    [No Abstract]   [Full Text] [Related]  

  • 75. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
    Peters N; Wieners G; Pech M; Hengst S; Rühl R; Streitparth F; Lopez Hänninen E; Felix R; Wust P; Ricke J
    Strahlenther Onkol; 2008 Jun; 184(6):296-301. PubMed ID: 18535804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiotherapy for pediatric brain tumors: when and how.
    Knab B; Connell PP
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S69-77. PubMed ID: 18076312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-dose-rate brachytherapy in a large squamous cell carcinoma of the hand.
    Fabrini MG; Perrone F; De Liguoro M; Cionini L
    Brachytherapy; 2008; 7(3):270-5. PubMed ID: 18599358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel device for intravaginal electronic brachytherapy.
    Schneider F; Fuchs H; Lorenz F; Steil V; Ziglio F; Kraus-Tiefenbacher U; Lohr F; Wenz F
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1298-305. PubMed ID: 19545794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The TDF (time-dose-fractionation) model in brachytherapy].
    Fadeeva MA; Datsenko VS; Klepper LIa; Podliashchuk EL; Ustinova VF
    Med Radiol (Mosk); 1988 Oct; 33(10):25-30. PubMed ID: 3185185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The half-life of high dose rate Ir-192 sources.
    Podgorsak MB; DeWerd LA; Paliwal BR
    Med Phys; 1993; 20(4):1257-9. PubMed ID: 8413038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.